1653.1000 -1.60 (-0.10%)
NSE Oct 07, 2025 15:31 PM
Volume: 2.2M
 

1653.10
-0.10%
Angel Broking
The company's sales for 1QFY2017 came in higher than expected at Rs8,007cr V/s Rs7,414cr expected and V/s Rs6,526cr in 1QFY2016, a yoy growth of 22.7%, mainly driven by exports. On the operating front, the EBITDA margin came in at 33.5% V/s 29.5% expected and V/s 23.5% in 1QFY2016, mainly driven by gross margin expansion (76.9% in 1QFY201..
Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
Recommended